These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome. Brennan L; Teede H; Skouteris H; Linardon J; Hill B; Moran L J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835 [TBL] [Abstract][Full Text] [Related]
10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related]
11. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in patients with polycystic ovary syndrome. Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294 [TBL] [Abstract][Full Text] [Related]
13. The role of obesity in the development of polycystic ovary syndrome. Motta AB Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149 [TBL] [Abstract][Full Text] [Related]
14. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Balen AH; Morley LC; Misso M; Franks S; Legro RS; Wijeyaratne CN; Stener-Victorin E; Fauser BC; Norman RJ; Teede H Hum Reprod Update; 2016 Nov; 22(6):687-708. PubMed ID: 27511809 [TBL] [Abstract][Full Text] [Related]
15. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208 [TBL] [Abstract][Full Text] [Related]
16. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Cattrall FR; Healy DL Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148 [TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140 [TBL] [Abstract][Full Text] [Related]
20. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]